Amunix is a series b startup based in United States. 2 investors tracked.
Based in the United States, Amunix is a startup founded in 2016. Its most recent tracked round is Series B. Brouky records 2 investors associated with the company.
masked, protease-activated immune-oncology therapeutics
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.